BioSpace News Archive

Can-Fite BioPharma Ltd. today announced its VP of Business Development, Dr. Sari Fishman, will participate in BioEquity Europe which takes place on May 14th – 16th, 2023 in Dublin, Ireland.

BriaCell Therapeutics Corp. announces that the Company has signed a Master Service and Technology Agreement agreement with Prevail InfoWorks, Inc., a Philadelphia, PA based Contract Research Organization, to provide clinical services and technologies for BriaCell’s upcoming pivotal study in advanced metastatic breast cancer.

Emergent BioSolutions announced it has completed the sale of its travel health business to Bavarian Nordic.

Vir Biotechnology, Inc. announced the appointment of Jeff Calcagno, M.D., as Executive Vice President and Chief Business Officer.

ChomiX Biotech Co., Ltd. announced the completion of millions of dollars Pre-A+ Financing by TigerYeah Capital,old shareholder Tsinghua Innovation Ventures, and Morning Spring Venture.

ContraFect Corporation (Nasdaq: CFRX) today announces business updates and financial results for the first quarter ended March 31, 2023.

IceCure Medical Ltd. announced that it will release its financial and operational results for the three months ended March 31, 2023 with a press release prior to the market open on Monday, May 22, 2023 and will host a conference call at 10:00 a.m. ET that day to discuss the results and corporate developments.

BiOneCure Therapeutics, Inc. has announced a strategic collaboration with Nanjing Leads Biolabs to develop a range of innovative anti-drug conjugates (ADCs) for treating solid tumors.

Seelos Therapeutics, Inc. today provided a clinical update and reported its financial results for the first quarter ended March 31, 2023.

Fulcrum Therapeutics, Inc.®, a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, announced the appointment of Alex C. Sapir as chief executive officer and president, effective July 1st, 2023.